pancreatic cancer 結果共5筆

Discover how Taiwan is addressing the alarming rise in cancer rates among young adults, with innovative AI-powered detection methods and a focus on healthy lifestyle changes.

Taiwan’s most common cancer has shifted from colorectal cancer to lung cancer, according to the Health Promotion Administration (HPA). This change was observed in 2021, ending a 15-year record held by colorectal cancer. The HPA’s report listed the top 10 cancers, with lung and colorectal cancers being the most common. Other cancers on the list include breast, liver, oral, prostate, thyroid, stomach, skin, and pancreatic cancer. Pancreatic cancer notably made the list for the first time. Dr. Chen Jin-shing, chief of surgery at National Taiwan University Hospital, explained that the shift is not surprising as lung cancer has been the leading cause of cancer-related deaths for the past decade. The HPA’s Cancer Prevention and Control Division director, Lin Li-ju, highlighted an increase in early lung cancer detection following the introduction of low dose computed tomography (LDCT) screening in 2022. In 2021, there were 121,762 new cases of cancer registered in Taiwan, marking the first decline in new patient numbers. On average, a person was diagnosed with cancer every 4 minutes and 19 seconds. HPA Director-General Wu Chao-chun urged individuals to reduce their risk factors and recommended regular screenings for early detection and treatment, especially for those at high risk.

Explore the latest 2021 cancer statistics in Taiwan, where lung cancer has now surpassed colorectal cancer as the most prevalent. The report highlights significant trends, including the rise of pancreatic cancer in the top ten list.

Taiwan’s national health insurance program will expand its coverage to include the cost of duodenal stents for patients with gastric, biliary, pancreatic, and duodenal cancers starting from Dec. 2023. This change is expected to benefit 242 patients annually, according to the National Health Insurance Administration (NHIA). Previously, patients had to pay out-of-pocket for duodenal stents, which cost between NT＄60,000 to NT＄80,000. With the national health insurance now covering the entire cost, the timing for duodenal stents replacement will be determined on a case-by-case basis. Duodenal stents are crucial for patients diagnosed with stage 3 and stage 4 gastric, biliary, pancreatic, and duodenal cancers as they help unblock obstructed areas and allow patients to consume food orally, ensuring necessary nourishment.

根據世界衛生組織（WHO）的資料顯示，全球每年約有33萬人因罹患胰臟癌而死亡，且胰臟癌初期症狀不明顯，患者很難察覺而因此延誤就醫，根據英國媒體報導指出，胰臟癌死亡率約95％。英國胰臟癌協會（Pancreatic Cancer UK）提醒大眾，只要出現以下「五種症狀」就盡早去醫院檢查。